Blue Bell Private Wealth Management, LLC Iterum Therapeutics PLC Transaction History

Blue Bell Private Wealth Management, LLC

  • $442 Million
  • Q1 2024

A detailed history of Blue Bell Private Wealth Management, LLC transactions in Iterum Therapeutics PLC stock. As of the latest transaction made, Blue Bell Private Wealth Management, LLC holds 66 shares of ITRM stock, worth $75. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66
Holding current value
$75
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024
BUY
$1.24 - $2.18 $81 - $143
66 New
66 $0
Q4 2021

Jan 26, 2022
BUY
$0.39 - $0.74 $390 - $740
1,000 New
1,000 $0

Others Institutions Holding ITRM

# of Institutions
2
Shares Held
104
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $14.1M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Blue Bell Private Wealth Management, LLC Portfolio

Follow Blue Bell Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Bell Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Bell Private Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email